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Abstract: Cordycepin, an active ingredient in the insect fungus Cordyceps militaris, is in a category of compounds that exhibit significant
therapeutic activity. The aim of the present study was to investigate the effect of cordycepin on cell proliferation, apoptosis, and cell cycle
in A549 human lung cancer cells. MTT assay was used to evaluate the cytotoxic effect of cordycepin on A549 cell growth. Apoptotic
effect was observed using cell morphology, DAPI staining, and DNA fragmentation studies. Flow cytometry (FCM) analysis was used
to analyze cell cycle status after cordycepin treatment. Furthermore, apoptosis was assayed using annexin V-Alexa Fluor 488. Results of
MTT assay showed that cordycepin significantly inhibited cell proliferation with an IC50 value of 64 µg/mL. The number of rounding-up
cells increased with cordycepin treatment and changes in cellular morphology were seen. In DNA fragmentation studies, a typical ladder
pattern was observed on agarose gel and formation of apoptotic bodies was further confirmed using DAPI staining. The FCM analysis of
cordycepin-treated cells showed that apoptosis rate increased with the increase in dosage. In conclusion, cordycepin induces apoptosis
in A549 human lung cancer cell line and could be a potential therapeutic candidate for lung cancer treatment.
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1. Introduction
In the Western world, lung cancer is still a leading cause
of mortality, responsible for 170,000 deaths per year,
more than deaths due to breast, colon, and prostate
cancer combined (Danesi et al., 2003). Approximately
80%–85% of all lung cancers are classified as nonsmallcell lung cancer (NSCLC). It is very difficult to cure
NSCLC, even in the early stage, as it develops resistance
against chemotherapeutic agents. Therefore, treatment of
NSCLC remains elusive despite the availability of a variety
of chemotherapeutic agents that exhibit sophisticated
mechanisms of action (Kim et al., 2003; Jemal et al., 2010;
Vejselova and Kutlu, 2015). In the last few decades, a
large number of natural bioactive metabolites, including
paclitaxel, vinblastine, and camptothecin, have been
isolated and used for cancer treatment (Kosty et al.,
1994; Douillard et al., 2001; Koshkina et al., 2003).
The inadequate availability of cancer treatment invites
scientific communities to propose the development of
novel therapeutic strategies for lung cancer treatment.
Apoptosis, also referred to as programmed cell death,
is an important mechanism of many anticancer drugs,
including cordycepin (Tuli et al., 2013).
* Correspondence: hardeep.biotech@gmail.com
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The biometabolite cordycepin was first isolated
from the fermented broth of the medicinal mushroom
Cordyceps militaris (Cunningham et al., 1950), which is
an entomopathogenic fungus that grows parasitically over
lepidopteran larvae and insect pupae. The genus Cordyceps
is well known in traditional Chinese medicine and exhibits a
variety of clinical health effects including immunomodulatory,
anticancer, antioxidant, antiinflammatory, and antimicrobial
activities. Cordycepin is a type of nucleoside analogue that
is structurally similar to adenosine, except that it lacks a
3’ hydroxyl group. It is known to interfere with a number
of biochemical and molecular processes, such as purine
biosynthesis, DNA/RNA synthesis, and mammalian target of
rapamycin signal transduction pathway (Tuli et al., 2014b).
In ethnopharmacological studies, Cordyceps extract has
been shown to induce apoptosis (Park et al., 2009; Thakur et
al., 2011) in human lung carcinoma cells. To the best of our
knowledge there is no scientific report available in support
of the apoptotic effect of cordycepin on A549 human lung
cancer cells. The aim of the present study was to extract
cordycepin from fermented broth of Cordyceps militaris and
to evaluate its apoptotic effect on the A549 lung cancer cell
line.
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2. Material and methods
2.1. Chemicals and microbial strain
Chemicals and nutrient medium ingredients of analytical
grade were purchased from Sigma Chemical Corporation
(USA), E-Merck India, and HiMedia Ltd. (India).
Cordyceps militaris 3936 was procured from the microbial
type culture collection at IMTECH, Chandigarh, India,
and it was regularly maintained on potato dextrose agar
(PDA) slants and stored at 4 °C.
2.2. Production, extraction, and purification of
cordycepin
Cordyceps militaris 3936 was initially grown on PDA
medium in a petri dish and then transferred to the seed
culture medium by punching out 5 mm of the agar plate
culture with a sterilized cork borer. The seed culture was
grown in a 250-mL flask containing 50 mL of basal medium
(glucose 15 g L–1, peptone 5 g L–1, KH2PO4 3 g L–1, K2HPO4
1 g L–1) at 25 °C on a rotary shaker incubator at 150 rpm
for 4 days. The batch-mode fermentation experiments
were performed in a 1000-mL flask containing 500 mL of
the medium with 4% (v/v) inocula of the seed culture. The
inoculated bottles were initially incubated at 25 °C for 7
days in stationary phase and then transferred to shaking
mode for 10 days followed by stationary condition again
for 7 days. Cordycepin was extracted and purified from
fermented culture medium according to the procedure we
described previously (Tuli et al., 2014a, 2014c).
2.3. Cell culture
A549 human lung cancer cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/
mL streptomycin sulfate. The cells were maintained at 37
°C in a humidified 5% CO2 atmosphere.
2.4. Cytotoxicity assay
MTT assay was performed on A549 human lung cancer
cells to determine cell viability (Lu et al., 2014). Briefly, 4 ×
103 cells were seeded in 96-well plates. After incubation for
24 h at 37 °C under 5% CO2 in a humidified atmosphere,
cells were exposed to different concentrations of cordycepin
ranging from 0 to 100 µg/mL for 48 h. MTT solution
(10 µL, 5 mg/mL) was added to each well and further
incubated for 4 h at 37 °C. The medium was removed
and formazan crystals were dissolved by adding 100 µL
of DMSO into each well and then shaking for another 20
min. Optical density (OD) was measured at 570 nm with
a microplate reader (Bio-Rad) and percentage of viability
was calculated as follows:
Percent (%) viability = 100 × mean of test OD / mean
of control OD,
Percent (%) cytotoxicity = 100 – (percent viability).
2.5. 4’,6-Diamidino-2-phenylindole (DAPI) staining
Cells were grown on cover slips for 24 h followed by

treatment with cordycepin (40 and 80 µg/mL) for 48 h.
Then medium was removed and cells were washed with
PBS and fixed in 4% paraformaldehyde for 10 min at room
temperature. Fixed cells were washed with PBS and stained
with 2.5 µg/mL 4,6-diamidino-2-phenylindole solution
for 10 min at room temperature. The cells were again
washed twice with PBS and analyzed under fluorescence
microscope.
2.6. DNA fragmentation assay
In order to further investigate if cordycepin could induce
cell apoptosis, fragmentation assay was performed
according to manufacturer’s instructions (Apoptotic DNA
Ladder Kit, Roche, Germany). Cells were grown in the
presence of various concentrations (0, 40, and 80 µg/mL)
of cordycepin for 48 h. After cordycepin treatment, A549
cells were harvested and subjected to DNA extraction and
fragmentation assay. Approximately 10 µg of DNA was
loaded onto 1% agarose gel using gel loading dye followed
by electrophoresis and run at 50 V for 90 min. Visualization
was done under UV transilluminator and photographed in
the gel doc system (Vilber Lourmat, Germany).
2.7. Cell cycle analysis
A549 human lung cancer cells (50 × 104) were seeded
in 24-well plates with complete DMEM medium. After
70%–80% confluence, cells were treated with and without
cordycepin-containing medium for 24 h. Cordycepintreated and untreated cells were harvested, washed with
PBS, and placed in 70% ethanol overnight at –20 °C. After
fixation, cells were resuspended in 400 µL of PBS and
added to 50 µL of propidium iodide (PI) solution (400
µg/mL) and 50 µL of RNase solution (1 mg/mL) followed
by 30 min of incubation at 37 °C under dark conditions.
Cell cycle analysis was done on a BD FACS Calibur flow
cytometer using BD CellQuest, after gating out doublets in
the PI area vs. width plot. Cell fractions in different phases
of the cell cycle were determined using Cyflogic (Cyflo
Ltd., Finland) analysis software.
2.8. Detection of apoptosis using annexin V-Alexa Fluor
488
A total of 5 × 104 cells were cultured in 24-well plates
overnight followed by treatment of cordycepin at
concentrations of 40, 60, 80, and 100 µg/mL. After 24 h
of treatment, cells were harvested and resuspended in
annexin V binding buffer. Cells were stained with 5 μL
of antiannexin V-Alexa Fluor 488 (Molecular Probes,
USA) and PI according to the manufacturer’s instructions
followed by analysis on the BD FACS Calibur equipped
with Cyflogic (Cyflo Ltd.) software.
3. Results
In this study, the fermented broth of Cordyceps militaris
was extracted with various solvents such as hexane,
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chloroform, and butanol. Cordycepin was detected in
butanolic fractions using various identification tools such
as TLC, spectrophotometer, and HPLC. The butanolic
fraction was further eluted on a silica gel column with a
stepwise gradient of methanol:chloroform (5:95, 15:85,
25:75, 35:65, 45:55, and 55:45) and 6 fractions were obtained
(F1–F6). Presence of cordycepin was detected in fraction
F2 by TLC, which was subfractionated into 4 fractions (S1–
S4) using elution gradient methanol:chloroform (15:85).
Subfraction S3 was found to carry cordycepin, which was
further vacuum-dried and recrystallized in methanol,
giving a white/creamy powdery product. Spectral analysis
of purified cordycepin was performed using UV, HPLC,
and NMR spectroscopy and the data were consistent with
our earlier published values (Tuli et al., 2014a, 2014c). We
performed anticancer assays to examine the apoptotic
effect of cordycepin on A549 human lung cancer cell line.
3.1. Cordycepin inhibits the proliferation of A549 lung
cancer cells
The effect of cordycepin on the growth and viability of
A549 cell lines was observed using MTT assay. After 48 h
of treatment with different concentrations of cordycepin,
a significant dose-dependent decrease in the number of
metabolically active viable cells was observed (Figure 1).
The results showed that cordycepin has potential to inhibit
the growth of A549 with an IC50 value of 64 µg/mL.
3.2. Cordycepin-induced morphological change
The morphological changes were observed in cordycepintreated cells under phase contrast microscope. Untreated
cells were polygonal in shape, whereas the treated cells
appeared with blebbing of plasma membrane and loss
of cell structure and cell adhesion property. The number
of floating cells in the cordycepin-treated group was
greater than in the control group. These observations

suggested that cordycepin is cytotoxic to A549 cells in a
concentration-dependent manner.
3.3. DAPI and DNA fragmentation assay
The DAPI staining of A549 cells treated with cordycepin
indicated that cells had undergone morphological changes
including cell shrinkage, along with the formation of
preapoptotic bodies, which are indicative of apoptosis.
DNA fragmentation, another hallmark known for
induction of apoptosis, was also analyzed in cordycepintreated cells. The typical ladder pattern of DNA
fragmentation was noticed on agarose gel (1%), pointing
towards the apoptotic effect of cordycepin on A549 lung
cancer cells (Figure 2).
3.4. Cell cycle analysis
Flow cytometric analysis was carried out to analyze cell
cycle distribution via apoptosis induction. Apoptosis is an
important mechanism in many anticancer drugs, including
cordycepin (Tuli et al., 2013). In the present study, the
A549 cells were treated with various concentrations of
cordycepin for 24 h and stained with PI. Results showed
that a significant proportion of cells were in the sub-G1
phase and apoptosis rates increased with the increase in
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Figure 1. The inhibitory effect with different concentrations of
cordycepin on A549 cell growth. The data are represented as the
mean ± SD of 3 independent experiments.
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Figure 2. Gel electrophoresis patterns of isolated DNA from
A549 cells: lane 1, genomic DNA of cordycepin-untreated cells;
lanes 2 and 3, genomic DNA of cordycepin-treated cells at
concentrations of 40 and 80 µg/mL, respectively.
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cordycepin dosages (Figure 3a). The histograms in Figure
3b represent cells from the untreated cultures (control)
and from the cultures treated with the cordycepin, which
affects the cell cycle distribution and induces apoptosis.
3.5. Annexin V/PI staining
To further validate the apoptotic effect of cordycepin,
cells were stained with annexin V/PI and analyzed by
flow cytometry (FCM). Annexin V/PI staining revealed
that cordycepin (40–100 µg/mL) significantly induced
apoptotic cell death in a dose-dependent manner. In Figure
4, the plot between annexin V and PI from the gated cells
shows the percentage of viable and nonapoptotic (annexin
V–PI–), early (annexin V+PI–), and late (annexin V+PI+)
apoptotic cells at various concentrations of cordycepin. We
found that cordycepin was able to induce apoptosis even at
40 µg/mL concentration in A549 human lung cancer cells.
Percentage of live cells was higher in untreated cells and it
was decreased with concomitant increase in apoptotic cells
as a result of treatment with cordycepin.
4. Discussion
Cordyceps militaris has been used as a traditional Chinese
medicinal mushroom for the treatment of many diseases,
including cancer. More recently, many studies have shown
that the extracts of C. militaris or the bioactive metabolite

cordycepin may induce apoptosis in various cell lines such
as human colorectal cancer cell lines (SW480 and SW620),
breast cancer cell line MDA-MB-231, leukemia (U937 and
THP-1), neuroblastoma SK-N-BE(2)-C (CRL-2268), and
melanoma SK-Mel-2 (HTB-68) cell lines (Park et al., 2005;
Lee et al., 2006; Lui et al., 2007; Wu et al., 2007; Paterson,
2008; Tuli et al., 2013). Apoptosis is characterized mainly
by a series of distinct changes in cell morphology, such as
blebbing, loss of cell attachment, cytoplasmic contraction,
DNA fragmentation, and other biochemical changes
including the activation of caspases through extrinsic and/
or intrinsic mitochondrial pathways (Tuli et al., 2013).
However, the apoptotic effect of the active ingredient of
Cordyceps, i.e. cordycepin, on A549 cells has not yet been
studied in detail. In this study we extracted cordycepin from
fermented broth of Cordyceps militaris and observed its
inhibitory effect on A549 cell growth in a dose-dependent
manner. Cellular morphology and DAPI staining of drugtreated cells showed characteristics typical of apoptosis.
Furthermore, the cell cycle analysis by flow cytometer
of cordycepin-treated A549 cells revealed apoptosis
in a concentration-dependent manner. FCM is one of
the best methods to detect and quantify apoptosis after
drug treatment (Wlodkowic et al., 2009). Significant
accumulations of cells were found in the sub-G1 phase.

80
70

(b)

G0/G1
S

60

G2/M

50

Apoptotic

40
30
20
10
0

0µg

40µg
60µg
80µg
Concentrations (µg/mL)

100µg

Figure 3. Apoptotic effect of cordycepin on A549 lung cancer cells determined by flow cytometric assay. (a) Representation of flow
cytometric plots at various concentrations (0, 40, 60, 80, and 100 µg/mL) of cordycepin after 24 h of treatments. (b) The histograms
represent the redistribution of cells in the cordycepin-treated group in comparison to untreated cells.
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Figure 4. (a) A549 cells were treated with cordycepin at various concentrations (0, 40, 60, 80, and 100 µg/mL) for 24 h and
examined using annexin V/PI staining on a flow cytometer. (b) Concentration vs. percentage of dead cells in cordycepin-treated
annexin V/PI stained A549 cells.

Furthermore, the percentage of annexin V+ cells also
increased with the increase in cordycepin dosage. In
the untreated/control sample, the majority of cells
(86%) were viable and nonapoptotic (annexin V–PI–). In
contrast, when cells were treated with 40–100 µg/mL of
cordycepin for 24 h, the percentages of annexin V–PI–cells
were significantly decreased up to 41.99%. Similarly the
percentage of early and late apoptotic cells increased in
comparison to untreated cells. These results demonstrated
that the growth inhibitory effect of cordycepin in A549
human lung cancer cell line might be associated with the
induction of apoptotic cell death.
In conclusion, our study showed that there is a
concentration-dependent cytotoxic effect of cordycepin
on the human lung cancer A549 cell line. Cordycepin
inhibits the cell cycle progression and leads to
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accumulation of cells in the sub-G1 phase, which
results in apoptosis induction. However, further studies
are required to elucidate the exact mechanism at the
molecular level underlying the apoptotic property of
cordycepin and to propose a novel therapeutic strategy
for cancer treatment.
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